ATROVENT HFA

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

35 API Suppliers, 9 USDMF, 8 CEP/COS, 1 JDMF, 5 EU WC, 9 KDMF, 14 NDC API, 20 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

27 Drugs in Development

27 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

270 FDF Dossiers, 45 FDA Orange Book, 160 Europe, 17 Canada, 4 Australia, 24 South Africa, 20 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SPRAY, METERED;NASAL - 0.021MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - 0.042MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;INHALATION - EQ 0.083% BASE;0.017% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 Kirsch Pharma, 5 Actylis, 1 Finar

EXCIPIENTS BY APPLICATIONS

6 Parenteral, 2 Solubilizers, 1 Thickeners and Stabilizers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 16 News #PharmaBuzz

GLOBAL SALES INFORMATION

19 US Medicaid Prescriptions, 30 Regulatory FDF Prices, 1 Annual Reports

MARKET PLACE

11 APIs, 6 FDF Dossiers, 1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

5 US Patents, 2 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 11 Others

$ Xls

Filters

FILTER :

filter Product Reset all filters

1 All

01 1Combivent

01 Brand Name : Combivent

Ipratropium Bromide, Albuterol

International Sweetener Colloquium

Not Confirmed

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

ATROVENT HFA

ATROVENT HFA

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

35 API Suppliers

9 USDMF

8 CEP/COS

1 JDMF

5 EU WC

9 KDMF

14 NDC API

20 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

27 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

270 FDF Dossiers

45 FDA Orange Book

160 Europe

17 Canada

4 Australia

24 South Africa

20 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SPRAY, METERED;NASAL - 0.021MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SPRAY, METERED;NASAL - 0.042MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;INHALATION - EQ 0.083% BASE;0.017% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 Kirsch Pharma

5 Actylis

1 Finar

EXCIPIENTS BY APPLICATIONS

6 Parenteral

2 Solubilizers

1 Thickeners and Stabilizers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow

16 News #PharmaBuzz

GLOBAL SALES INFORMATION

19 US Medicaid Prescriptions

30 Regulatory FDF Prices

1 Annual Reports

MARKET PLACE

11 APIs

6 FDF Dossiers

1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

5 US Patents

2 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM

11 Others

Filters

01

Brand Name : Combivent

Brand Name : Combivent

SPRAY, METERED;NASAL - 0.021MG/SPRAY Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SPRAY, METERED;NASAL - 0.042MG/SPRAY Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION;INHALATION - EQ 0.083% BASE;0.017% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons